In a webinar that was held World Thrombosis Day 2022, two coagulation experts—Prof Anna Falanga, Professor of Hematology at University of Milan Bicocca, and Cinzia Giaccherini, a research biologist with more than 10 years of experience in hemostasis and thrombosis—discussed the predictive role of biomarkers in cancer-associated thrombosis (CAT). Prof Anna Falanga began by presenting […]
Since 2020, Thailand has used HPV DNA tests as a way to optimise primary screening programmes for cervical cancer. The country conducted internal studies on the cost-effectiveness of HPV tests within primary screening and found it economical. To increase coverage amongst the unscreened or under-screened population, self-sampling was introduced to address cultural and/or religious barriers
Advancing women’s health: optimising cervical cancer screening in Thailand Read More »
HPV screening programmes are being rolled out across many countries in a bid to eliminate cervical cancer by 2030, a target that has been set out by the World Health Organisation. As more countries gain access to innovative technology and greater experience in cervical cancer screening, some are exploring updating screening algorithms in order to
Advancing women’s health: HPV screening methods in Singapore Read More »
At pro-COAG, an annual scientific and educational event on coagulation sponsored by Roche Diagnostics that was last held in Mar 2022, Prof Ng Heng Joo, Head and Senior Consultant at the Department of Haematology at Singapore General Hospital in Singapore, reviewed the causation, development and treatment of venous thrombotic events in cancer and inflammation. Cancer
Thrombosis in cancer and inflammation: insights from Prof Ng Heng Joo Read More »
With face-to-face conferences and scientific symposiums back on, the Lab Insights team recently attended the 14th meeting of the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN 2022). Distinguished speakers from around the world gathered to talk about human papillomavirus (HPV) and the several cancers it can cause, the most notable among them being
Advancing women’s health: key takeaways from AOGIN 2022 Read More »
For many patients with early-stage lung cancer, targeted immunotherapies have transformed treatment options and prognosis. These immunotherapies are now being used earlier in the process and have been shown to improve not just disease-free survival but also overall survival. In a recent webinar, oncology and pathology experts from Thailand and Korea offered insight into the
NSCLC biomarker testing and targeted immunotherapies improve lung cancer outcomes Read More »
Summer Ng was 24 years old when she was diagnosed with cervical cancer and told she could not become a mother. In this candid fireside chat with Yvonne Ng, founder of the Alliance for Active Action Against HPV (A4HPV), Summer discusses her experience of coping with the diagnosis and charting a path through a medical
Cervical cancer survivor shares journey from diagnosis to recovery Read More »
Lung cancer has seen tremendous advances over the past decade with the emergence of targeted therapies directed against mutant onco-proteins and immune checkpoint inhibitors, including several that are being applied outside of the advanced metastatic setting. In a recent webinar hosted by Dr Jennifer Thompson, Oncology Medical & Scientific Affairs Manager at Roche Diagnostics Asia
Early stage lung cancer: Asia’s evolving testing and treatment landscape Read More »
To understand how the clinical lab community can help bring precision oncology to Thailand, Lab Insights spoke with Prof Manop Pithukpakorn, a physician and geneticist in the Faculty of Medicine in Siriraj Hospital at Mahidol University, Thailand. Drawing on his experience as a clinician and researcher who holds leadership positions in several national cancer initiatives,
To learn more about how Thailand plans to build its precision oncology ecosystem, Lab Insights spoke with Prof Manop Pithukpakorn, a physician and geneticist who works in the Faculty of Medicine in Siriraj Hospital at Mahidol University, Thailand. Prof Manop shares insights from his experiences with the Siriraj Centre of Research Excellence in Precision Medicine
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
